Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (81-90 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|February 22, 2022
Improved therapeutic index of an acidic pH-selective antibodyPeter S Lee, Katherine G MacDonald, Evan Massi, et al.
Mabs|March 14, 2022
Computational models for studying physical instabilities in high concentration biotherapeutic formulationsMarco A Blanco
Mabs|April 7, 2022
Enhanced anti-angiogenetic effect of transferrin receptor-mediated delivery of VEGF-trap in a glioblastoma mouse modelPeng Zhao, Yasuaki Anami, Peng Gao, et al.
Mabs|April 5, 2022
Upstream cell culture process characterization and in-process control strategy development at pandemic speedJianlin Xu, Jianfa Ou, Kyle P McHugh, et al.
Mabs|October 9, 2018
Evaluation of similar quality attribute characteristics in SB5 and reference product of adalimumabNayoung Lee, JongAh Joanne Lee, Hahymn Yang, et al.
Mabs|October 9, 2018
Comprehensive characterisation of the heterogeneity of adalimumab via charge variant analysis hyphenated on-line to native high resolution Orbitrap mass spectrometryFlorian Füssl, Anne Trappe, Ken Cook, et al.
Mabs|March 24, 2022
Suitability of transiently expressed antibodies for clinical studies: product quality consistency at different production scalesSara Rodriguez-Conde, Sophie Inman, Viv Lindo, et al.
Mabs|June 19, 2018
Corrigendum
Mabs|April 28, 2010
Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodiesFrank R Brennan, Laura Dill Morton, Sebastian Spindeldreher, et al.
Mabs|April 27, 2010
Structural and functional characterization of the trifunctional antibody catumaxomabDirk Chelius, Peter Ruf, Patrick Gruber, et al.
Pageof 184

Showing results (81-90 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|February 22, 2022
Improved therapeutic index of an acidic pH-selective antibodyPeter S Lee, Katherine G MacDonald, Evan Massi, et al.
Mabs|March 14, 2022
Computational models for studying physical instabilities in high concentration biotherapeutic formulationsMarco A Blanco
Mabs|April 7, 2022
Enhanced anti-angiogenetic effect of transferrin receptor-mediated delivery of VEGF-trap in a glioblastoma mouse modelPeng Zhao, Yasuaki Anami, Peng Gao, et al.
Mabs|April 5, 2022
Upstream cell culture process characterization and in-process control strategy development at pandemic speedJianlin Xu, Jianfa Ou, Kyle P McHugh, et al.
Mabs|October 9, 2018
Evaluation of similar quality attribute characteristics in SB5 and reference product of adalimumabNayoung Lee, JongAh Joanne Lee, Hahymn Yang, et al.
Mabs|October 9, 2018
Comprehensive characterisation of the heterogeneity of adalimumab via charge variant analysis hyphenated on-line to native high resolution Orbitrap mass spectrometryFlorian Füssl, Anne Trappe, Ken Cook, et al.
Mabs|March 24, 2022
Suitability of transiently expressed antibodies for clinical studies: product quality consistency at different production scalesSara Rodriguez-Conde, Sophie Inman, Viv Lindo, et al.
Mabs|June 19, 2018
Corrigendum
Mabs|April 28, 2010
Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodiesFrank R Brennan, Laura Dill Morton, Sebastian Spindeldreher, et al.
Mabs|April 27, 2010
Structural and functional characterization of the trifunctional antibody catumaxomabDirk Chelius, Peter Ruf, Patrick Gruber, et al.
Pageof 184